This week, Tilray Brands’ (NASDAQ:TLRY) financial results will put the stock in focus. The numbers are coming at a moment when the stock is nearing its lowest point of the year, $1.60.
Tilray was once one of cannabis’ most successful companies. It has fallen by more than 95% over the last five years. The market cap of Tilray has dropped to $1.5 Billion, which is a significant amount less than what it paid for Aphria’s acquisition in 2020.
Tilray Brands Earnings Ahead
Tilray Brands Earnings Ahead
Tilray Brands’ fundamentals have been mixed over the years. The company’s revenues are expected to increase from $179.3 in 2019 up to $627 in 2023. In the past twelve months, its revenues rose to $743 millions.
These numbers are impressive, but they’re mainly due to its acquisitions. The company acquired 17 companies, such as HEXO Ciders, Square Mile Ciders, Blue Point Brewing, MedMen and Square Mile Cider.
Its stock price has fallen dramatically in recent years due to its extremely poor bottom line. The company’s net loss jumped up from $25 million to $1.45 billion during the past financial year.
Tilray Brands, as a result of this, has become a company that is highly diluted in recent years. This has led to its shares outstanding jumping from 110 million in 2020, up to 774 millions today. The company has recently announced that they will raise $250 million in order to purchase assets in the US.
Recent regulatory measures have encouraged the entry of cannabis into the US market. The US may reclassify marijuana as a safer drug. Chuck Schumer has supported cannabis banking measures in the US.
Tilray Brands made recent progress. Recently, it received a license to grow in Germany as a result of new laws that are crypto-friendly. It was approved by Portugal to launch a third product of medical cannabis.
It has also invested in alcohol beverages. In 2023, its biggest investment was the purchase of eight beers from AB InBev. SweetWater Brewing, which includes ten different brands such as Widmer or Redhook was also purchased.
Tilray Brands Earnings Ahead
Tilray Brands Earnings Ahead
Tilray Brands’ earnings report on Monday will likely be the next major catalyst in its stock price. Analysts anticipate that the company’s revenue will have risen to $227m in the past quarter from $184m in the previous period.
Analysts expect the company to generate $783 million in revenue for the entire year. This is up from the $627 million it generated a year ago. Tilray, however, has failed to meet analyst expectations for the past four quarters.
In this report, investors will be looking at the headline figures for revenue and profit. Investors will also be looking at its alcohol beverage segment and if it can offset its volatile cannabis sector.
Recent financial reports showed that the company’s total revenue increased by 30 percent in the third quarter. The alcohol division brought in $54.7m, which is a 165% rise from last year. The brands acquired by AB InBev were responsible for this growth.
We can therefore see, that with its cannabis revenue of $63.4 millions, the brand is becoming more diverse. Other revenue numbers came from the company’s distribution and wellness businesses. These brought in respectively $56,8 million and $14 million.
Tilray is viewed with a neutral opinion by analysts. This year, only analysts at Zuaniac and CIBC provided their forecasts. Stocks are expected to reach an average price of $2.38 – a significant increase from the $1.90 they currently trade at.
Tilray Brands has a good risk-reward ratio, according to me. The technicals will demonstrate that while the stock may still fall, it is possible for it to bounce back, too.
Tilray Brands Stock Price Analysis
Daily chart of the TLRY shares shows that they have been heavily pressured for a long time. The price has been firmly supported around $1.50 since last July. The price movement is an indication that the bears have been struggling to get below this support level.
The pattern has also been formed by a double bottom with a neckline at $2.96. This is usually one of the bullishest patterns on the market. Stocks are also consolidating near the Exponential Moving Avgs. (EMA) of 50 and 25 days.
The Tilray share price is likely to bounce back when buyers aim for the $2.96 key resistance level, which is approximately 64% higher than the current value. It could also lose support at $1.50. The next level to monitor is $1.
The post Tilray Brands stock has reached a bottom: July 29 is the key date appeared first on ICD
